Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 50, Issue 4, 2015, Pages 559-565

  Nakasone, H ^a,b   Fukuda, T ^c   Kanda, J ^b   Mori, T ^d   Yano, S ^e   Kobayashi, T ^f   Miyamura, K ^g   Eto, T ^h   Kanamori, H ⁱ   Iwato, K ^j   Uchida, N ^k   Mori, S ^l   Nagamura Inoue, T ^m   Ichinohe, T ⁿ   Atsuta, Y ^o,p   Teshima, T ^q   Murata, M ^p  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^g JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^h HAMANOMACHI HOSPITAL   (Japan)

ⁱ KANAGAWA CANCER CENTER   (Japan)

^j ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^k TORANOMON HOSPITAL   (Japan)

^l ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

ⁿ HIROSHIMA UNIVERSITY   (Japan)

^o JAPANESE DATA CENTER FOR HEMATOPOIETIC CELL TRANSPLANTATION   (Japan)

^p NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^q HOKKAIDO UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOSPORIN A; MELPHALAN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; ORGAN DISTRIBUTION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; WHOLE BODY RADIATION; YOUNG ADULT; ACUTE DISEASE; ALLOGRAFT; CLINICAL TRIAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MORTALITY; MULTICENTER STUDY; REGISTER; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGRAFTS; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; TRANSPLANTATION CONDITIONING;

EID: 84926408530     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.293     Document Type: Article

References (23)

1. Powles R. 50 years of allogeneic bone-marrow transplantation. Lancet Oncol 2010; 11: 305-306
2. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561
3. Harris AC, Ferrara JL, Levine JE. Advances in predicting acute GVHD. Br J Haematol 2013; 160: 288-302
4. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214-3219
5. Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119: 296-307
6. Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, et al. Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2013; 19: 1183-1189
7. Shi-Xia X, Hai-Qin X, Xian-Hua T, Bo F, Xiang-Feng T. Comparison of reduced intensity and myeloablative conditioning regimens for stem cell transplantation in patients with malignancies: a meta-Analysis. Clin Transplant 2011; 25: E187-E198
8. Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756-762
9. Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ, et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005; 105: 1810-1814
10. Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H, et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008; 26: 5728-5734
11. Mohty M, Malard F, Savani BN. High-dose total body irradiation and myeloablative conditioning before allogeneic stem cell transplantation: time to rethink? Biol Blood Marrow Transplant (e-pub ahead of print 20 September 2014; doi: 10.1016/j.bbmt.2014.09.010
12. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 2007; 86: 269-274
13. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reducedintensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367-369
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828
15. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-Term clinicopathologic study of 20 Seattle patients. Am J Med. 1980; 69: 204-217
16. Kanda Y. Investigation of the freely available easy-To-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452-458
17. Pérez-Simón JA, Díez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD, et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol 2005; 130: 394-403
18. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR, et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410-2415
19. Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, et al. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Br J Haematol 2005; 130: 575-587
20. Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999; 17: 2446-2453
21. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759
22. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213
23. Giebel S, Miszczyk L, Slosarek K, Moukhtari L, Ciceri F, Esteve J, et al. Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Cancer 2014; 120: 2760-2765